Running digitally for 2021, the 3rd Treg Directed Therapies Summit is the industry-led meeting focused on targeting and translating Treg modifying therapies with enhanced persistence and durability safely and at scale.
Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, to discuss how to robustly modify the Treg response through novel gene engineering and ensure scale and efficiency of cell sorting and isolation for effective cell expansion.
Navigate across 3 days packed with dedicated, interactive formats exploring how to optimize and bring to clinic Treg directed therapies to address huge unmet medical need in autoimmune, allergic, transplant, inflammatory indications.
Expert Speakers Include:
Co-Founder, President & CSO
co-Founder & VP Biology, Visiting Lecturer
Quell Therapeutics, King’s College London
Professor of Pathology & Laboratory Medicine and Chief of the Division of Transplant Immunology
Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine